[EN] CDK2 INHIBITORS AND USE THEREOF [FR] INHIBITEURS DE CDK2 ET LEUR UTILISATION
摘要:
The present disclosure provides a compound represented by structural formula (I) : or a pharmaceutically acceptable salt, or a stereoisomer thereof and their use in, e.g. treating a disease or disorder associated with CDK2. This disclosure also features compositions containing the same as well as methods of using and making the same.
[EN] CD73 INHIBITOR COMPOUNDS [FR] COMPOSÉS INHIBITEURS DE CD73
摘要:
The present invention relates to compounds of formula I shown below: wherein R1, X2, X3, X4, X5, X6, X7, X8and X9are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine CD73 activity is implicated, such as, for example, cancer.